Literature DB >> 15623714

Determinants of IV heparin treatment in patients with ischemic stroke.

W-P Schmidt1, P Heuschmann, D Taeger, H Henningsen, H-J Buecker-Nott, K Berger.   

Abstract

Management of acute ischemic stroke with IV unfractionated heparin is subject to debate. The authors evaluated patient-related and institutional factors influencing its use in 42 hospitals. Cardioembolic stroke type, carotid stenosis, atrial fibrillation, and treatment in stroke units or intensive care units significantly increased the probability of use. However, there are large unexplained variations in IV heparin use among hospitals.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15623714     DOI： 10.1212/01.wnl.0000147542.37657.2f

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  4 in total

1.  The glu298asp polymorphism in the nitric oxide synthase 3 gene is associated with the risk of ischemic stroke in two large independent case-control studies.

Authors:  Klaus Berger; Florian Stögbauer; Monika Stoll; Juergen Wellmann; Andreas Huge; Suzanne Cheng; Christof Kessler; Ulrich John; Gerd Assmann; E Bernd Ringelstein; Harald Funke
Journal:  Hum Genet       Date:  2006-12-13       Impact factor: 4.132

2.  Antithrombotic agents' use in patients with atrial fibrillation and acute cerebral ischemia.

Authors:  Charlotte Cordonnier; Didier Leys; Dominique Deplanque; Hilde Hénon
Journal:  J Neurol       Date:  2006-04-28       Impact factor: 4.849

Review 3.  A meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in nonhypertensive patients.

Authors:  Xingyu Wang; Suzanne Cheng; Victoria H Brophy; Henry A Erlich; Christine Mannhalter; Klaus Berger; Wolfgang Lalouschek; Warren S Browner; Yu Shi; E Bernd Ringelstein; Christof Kessler; Jan Luedemann; Klaus Lindpaintner; Lisheng Liu; Paul M Ridker; Robert Y L Zee; Nancy R Cook
Journal:  Stroke       Date:  2009-01-08       Impact factor: 7.914

4.  Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials.

Authors:  William N Whiteley; Harold P Adams; Philip M W Bath; Eivind Berge; Per Morten Sandset; Martin Dennis; Gordon D Murray; Ka-Sing Lawrence Wong; Peter A G Sandercock
Journal:  Lancet Neurol       Date:  2013-05-02       Impact factor: 44.182
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.